FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine for ages 16 and up

Entrance to FDA Building 1 at White Oak

The Food and Drug Administration granted full approval Monday to Pfizer and BioNTech’s COVID-19 vaccine for people 16 and older. It is the first COVID-19 vaccine to receive full FDA approval.

The vaccine will be marketed as Comirnaty. It has been available since December under an emergency use authorization, which continues to cover people ages 12 through 15.

The agency reviewed clinical follow-up and manufacturing information for its decision. Safety monitoring continues as the vaccine is administered.

Reporting source. Cover photograph: U.S. Food and Drug Administration, public domain.